Nausea Relief Chews Market
Nausea Relief Chews Market Analysis by Gastroesophageal Reflux Disease, Motion Sickness, and Sea Sickness from 2023 to 2033
Analysis of Nausea Relief Chews Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Nausea Relief Chews Market Outlook (2023 to 2033)
Newly-released nausea relief chews market analysis report by Fact.MR reveals that global sales of the nausea relief chews market in 2022 were held at US$ 334 million. With 7.2% projected growth from 2023 to 2033, the market is expected to reach a valuation of US$ 712.9 million by the end of the forecast period.
Nausea relief chews based on gastroesophageal reflux disease is expected to be the highest revenue-generating category, projected to grow at a CAGR of over 7% from 2023 to 2033.
| Attributes | Details |
|---|---|
|
Global Nausea Relief Chews Market Size (2022) |
US$ 334 million |
|
Global Nausea Relief Chews Market Size (2033) |
US$ 712.9 million |
|
Global Nausea Relief Chews Market CAGR (2023 to 2033) |
7.2% |
|
U.S. Nausea Relief Chews Market CAGR (2023 to 2033) |
7% |
|
Key Companies Covered |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue of Nausea Relief Chews Market from 2018 to 2022 Compared to Demand Outlook for 2023 to 2033
As per the research of the nausea relief chews market by Fact.MR - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value increased at around 5.6% CAGR. With an absolute dollar opportunity of US$ 356.1 million, the market is projected to reach a valuation of US$ 712.9 million by 2033.
What Key Drivers are Influencing the Market Expansion?
Nausea relief chews are a type of over-the-counter medication used to provide relief from nausea and vomiting. These chews are typically formulated with natural ingredients such as ginger, peppermint, or chamomile, which have been traditionally used to alleviate gastrointestinal discomfort. Nausea relief chews are available in different flavors and are designed to be chewed and swallowed like candy.
- In 2020, the global nausea relief products market was valued at over US$ 2.5 billion and it is expected to grow at a CAGR of 5.6% during the forecast period. Nausea and vomiting are common symptoms associated with various medical conditions such as pregnancy, motion sickness, chemotherapy, and post-operative recovery. With an increasing prevalence of these conditions, the demand for nausea relief chews is expected to rise in the upcoming years.
According to the International Agency for Research on Cancer (IARC), in 2018, about 18.1 million new cancer cases were diagnosed worldwide which increased to the next year was about 18.6 million new cancer cases. The most commonly diagnosed types of cancer worldwide are lung cancer, breast cancer, and colorectal cancer.
- In 2018, lung cancer accounted for 11.6% of all new cancer cases, followed by breast cancer with 11.6% and colorectal cancer with 10.2%. Nausea relief chews can provide several benefits for cancer patients who experience nausea and vomiting due to chemotherapy or radiation therapy. These chews are designed to deliver fast-acting relief for nausea, with a convenient and easy-to-use form. Thus, nausea relief chews witness an increase in sales due to the growing prevalence of cancer during the forecast period.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Region-Wise Analysis :
Which Region is projected to offer Significant Growth in the Market?
North America is a prominent shareholder in the market with a market size of US$ 93.5 million. It is projected that the region will have a market worth US$ 199.6 million by 2033.
In 2021, over 2.3 million new cancer cases were diagnosed and 30 thousand cases of lung and bronchus cancer were diagnosed in Canada. Besides, over 21 thousand deaths were caused due to lung cancer in 2020. Due to the rise in cancer cases, chemotherapy is a widely used treatment for various types of cancer which is also accompanied by side effects of nausea and vomiting. Nausea relief chews are formulated to deliver fast-acting relief for nausea and vomiting which is expected to influence the market growth in the forthcoming years.
Country-Wise Analysis :
United States Nausea Relief Chews Market Analysis :
The market in the United States is expected to grow to be worth US$ 172.1 million by 2033, with an absolute dollar growth of US$ 84.2 million from 2023 to 2033. The market in the country has grown at a CAGR of 5.3% from 2018 to 2022 and is expected to grow at a CAGR of 7% from 2023 to 2033.
In 2019, according to the American Cancer Society, an estimated 1.76 million new cancer cases were diagnosed in the United States. Breast cancer and lung cancer were the leading causes of death. Over 271 thousand cases diagnosed with breast cancer and about 228 thousand cases diagnosed with lung cancer.
Due to increase in the incidences of cancer, chemotherapy is used as a standard treatment for the all types of cancer which causes side-effects including nausea and vomiting. Nausea relief chews made from natural and herbal products used for the relieving of nausea and vomiting is expected to influence the market growth in the future.
Germany Nausea Relief Chews Market Analysis :
The market in Germany is expected to grow to be worth US$ 26.2 million by 2033, with an absolute dollar growth of US$ 11.9 million. The market in the country has grown at a CAGR of 4.5% from 2018 to 2022 and is expected to grow at a CAGR of 6.2% from 2023 to 2033.
According to the German Pancreatic Cancer Foundation, in 2020, the incidence of acute pancreatitis in the country had a population coverage of around 80 -100 cases per 100,000 people. The incidence of chronic pancreatitis is lower, estimated to be around 5-10 cases per 100,000 people per year. Nausea relief chews may be used as a part of the treatment for nausea and vomiting associated with pancreatitis, especially in cases of acute pancreatitis. The growing need for nausea chews for the treatment of nausea and vomiting is expected to influence the market growth in the upcoming years.
China Nausea Relief Chews Market Analysis :
In China, the market is expected to grow to be worth US$ 89 million with an absolute dollar growth of US$ 41.9 million. The market in China has grown at a CAGR of 5% from 2018 to 2022 and is expected to grow at a CAGR of 6.6% from 2023 to 2033.
In 2020, the market in China was valued at about US$ 50 million. The market is expected to grow at a CAGR of 10.4% during the forecast period, reaching a value of around US$ 1.2 billion by 2028. The demand for antiemetic drugs in China is likely to continue growing in the coming years due to the increasing prevalence of chronic diseases and a growing awareness of the use of antiemetic drugs. This is expected to influence the market growth in the forthcoming years.
India Nausea Relief Chews Market Analysis :
The market is expected to grow to be worth US$ 72.7 million by 2033, with an absolute dollar growth of US$ 30.9 million. The market in India has grown at a CAGR of 4.1% from 2018 to 2022 and is expected to grow at a CAGR of 5.7% from 2023 to 2033.
According to a study published in the Indian Journal of Gastroenterology, in 2018, the prevalence of irritable bowel syndrome (IBS) in India is estimated to be around 5-12%. This means that around 64 to 153 million people in India may be suffering from IBS. Nausea Relief Chews are generally over-the-counter medications which can help to alleviate nausea and vomiting. This contains ginger or peppermint that has shown anti-inflammatory and anti-nausea properties.
United Kingdom Nausea Relief Chews Market Analysis :
In United Kingdom, the market is expected to grow to be worth US$ 44.5 million with an absolute dollar growth of US$ 18.1 million. The market in Japan has grown at a CAGR of 3.5% from 2018 to 2022 and is expected to grow at a CAGR of 5.4% from 2023 to 2033.
In 2020, there were around 9 million people in the United Kingdom who experienced migraines while the prevalence rate of migraines in the UK was around 14% of the total population. Nausea relief chews are commonly used to help alleviate nausea that may be associated with migraines. The growing incidences of migraines will thus drive the market growth in the forthcoming years.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-Wise Insights
Which Indication of Nausea Relief Chews is projected to Witness Significant Growth?
The market through gastroesophageal reflux disease indication is projected to witness significant growth with a CAGR of 5.4% from 2018 to 2022. The market is expected to grow at a CAGR of 7% from 2023 to 2033.
Gastroesophageal Reflux Disease (GERD) is a chronic condition where stomach acid flows back into the oesophagus, causing irritation and inflammation. Symptoms may include heartburn, regurgitation, difficulty swallowing, and nausea. Nausea relief chews may help alleviate nausea associated with GERD. The convenience of these chews makes them a common choice for people, who prefer natural remedies and easy-to-use medication.
Through which Distribution Channel is the Market Projected to Witness Significant Growth?
The market is expected to witness growth through online sales at a CAGR of 5.2% from 2018 to 2022. The market is further expected to grow at a CAGR of 6.6% from 2023 to 2033.
Nausea relief chews includes various brands and products that are available over-the-counter (OTC) in pharmacies, drug stores, supermarkets, and online retailers. The growth of online sales may be driven by factors such as convenience, accessibility, and the ability to easily compare prices and products.
Competitive Analysis :
Key players in the market are Prestige Consumer Healthcare Inc., Megafood, Webber Naturals, Merck, Sanofi, Nauzene, Pepto Bismol, Ginger People, Emetrol Chewables and Cipla.
A few of the recent developments in the market are :
- In August 2021, Pfizer Consumer Healthcare announced the launch of its new product, Pepto Bismol Nausea Relief Chewables, which are designed to provide fast and effective relief from nausea, heartburn, and indigestion. The product is formulated with a combination of bismuth subsalicylate and ginger, which are known to have anti-nausea and anti-inflammatory properties.
- In January 2021, Pink Stork announced the launch of its new product, Morning Sickness Relief Chews which are designed specifically for pregnant women. The product is formulated with a combination of ginger and vitamin B6, and is intended to provide fast and effective relief from nausea and vomiting during pregnancy.
Segmentation of the Nausea Relief Chews Market :
-
By Indication :
- Gastroesophageal Reflux Disease
- Motion Sickness and Seasickness
-
By Distribution Channel :
- Online Sales
- Supermarkets/Hypermarkets
- Hospital Pharmacies
-
By Region :
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018-2022 and Forecast, 2023-2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Indication 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2018-2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2023-2033 5.3.1. Gastroesophageal Reflux Disease 5.3.2. Motion Sickness and Seasickness 5.4. Y-o-Y Growth Trend Analysis By Indication, 2018-2022 5.5. Absolute $ Opportunity Analysis By Indication, 2023-2033 6. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2018-2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2023-2033 6.3.1. Online Sales 6.3.2. Supermarkets/Hypermarkets 6.3.3. Hospital Pharmacies 6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018-2022 6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023-2033 7. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. Asia Pacific 7.3.5. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018-2022 and Forecast 2023-2033, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Indication 8.2.3. By Distribution Channel 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Indication 8.3.3. By Distribution Channel 8.4. Key Takeaways 9. Latin America Market Analysis 2018-2022 and Forecast 2023-2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Indication 9.2.3. By Distribution Channel 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Indication 9.3.3. By Distribution Channel 9.4. Key Takeaways 10. Europe Market Analysis 2018-2022 and Forecast 2023-2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 10.2.1. By Country 10.2.1.1. U.K. 10.2.1.2. Spain 10.2.1.3. Germany 10.2.1.4. Russia 10.2.1.5. Italy 10.2.1.6. France 10.2.1.7. Rest of Europe 10.2.2. By Indication 10.2.3. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Indication 10.3.3. By Distribution Channel 10.4. Key Takeaways 11. Asia Pacific Market Analysis 2018-2022 and Forecast 2023-2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. India 11.2.1.4. South Korea 11.2.1.5. Rest of Asia Pacific 11.2.2. By Indication 11.2.3. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Indication 11.3.3. By Distribution Channel 11.4. Key Takeaways 12. Middle East and Africa Market Analysis 2018-2022 and Forecast 2023-2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033 12.2.1. By Country 12.2.1.1. South Africa 12.2.1.2. GCC Countries 12.2.1.3. Rest of Middle East and Africa 12.2.2. By Indication 12.2.3. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Indication 12.3.3. By Distribution Channel 12.4. Key Takeaways 13. Key Countries Market Analysis 13.1. U.S. 13.1.1. Pricing Analysis 13.1.2. Market Share Analysis, 2022 13.1.2.1. By Indication 13.1.2.2. By Distribution Channel 13.2. Canada 13.2.1. Pricing Analysis 13.2.2. Market Share Analysis, 2022 13.2.2.1. By Indication 13.2.2.2. By Distribution Channel 13.3. Brazil 13.3.1. Pricing Analysis 13.3.2. Market Share Analysis, 2022 13.3.2.1. By Indication 13.3.2.2. By Distribution Channel 13.4. Mexico 13.4.1. Pricing Analysis 13.4.2. Market Share Analysis, 2022 13.4.2.1. By Indication 13.4.2.2. By Distribution Channel 13.5. U.K. 13.5.1. Pricing Analysis 13.5.2. Market Share Analysis, 2022 13.5.2.1. By Indication 13.5.2.2. By Distribution Channel 13.6. Spain 13.6.1. Pricing Analysis 13.6.2. Market Share Analysis, 2022 13.6.2.1. By Indication 13.6.2.2. By Distribution Channel 13.7. Germany 13.7.1. Pricing Analysis 13.7.2. Market Share Analysis, 2022 13.7.2.1. By Indication 13.7.2.2. By Distribution Channel 13.8. Russia 13.8.1. Pricing Analysis 13.8.2. Market Share Analysis, 2022 13.8.2.1. By Indication 13.8.2.2. By Distribution Channel 13.9. Italy 13.9.1. Pricing Analysis 13.9.2. Market Share Analysis, 2022 13.9.2.1. By Indication 13.9.2.2. By Distribution Channel 13.10. France 13.10.1. Pricing Analysis 13.10.2. Market Share Analysis, 2022 13.10.2.1. By Indication 13.10.2.2. By Distribution Channel 13.11. China 13.11.1. Pricing Analysis 13.11.2. Market Share Analysis, 2022 13.11.2.1. By Indication 13.11.2.2. By Distribution Channel 13.12. Japan 13.12.1. Pricing Analysis 13.12.2. Market Share Analysis, 2022 13.12.2.1. By Indication 13.12.2.2. By Distribution Channel 13.13. India 13.13.1. Pricing Analysis 13.13.2. Market Share Analysis, 2022 13.13.2.1. By Indication 13.13.2.2. By Distribution Channel 13.14. South Korea 13.14.1. Pricing Analysis 13.14.2. Market Share Analysis, 2022 13.14.2.1. By Indication 13.14.2.2. By Distribution Channel 13.15. South Africa 13.15.1. Pricing Analysis 13.15.2. Market Share Analysis, 2022 13.15.2.1. By Indication 13.15.2.2. By Distribution Channel 13.16. GCC Countries 13.16.1. Pricing Analysis 13.16.2. Market Share Analysis, 2022 13.16.2.1. By Indication 13.16.2.2. By Distribution Channel 14. Market Structure Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Market Share Analysis of Top Players 14.3.1. By Regional 14.3.2. By Indication 14.3.3. By Distribution Channel 15. Competition Analysis 15.1. Competition Deep Dive 15.1.1. Prestige Consumer Healthcare Inc. 15.1.1.1. Overview 15.1.1.2. Product Portfolio 15.1.1.3. Profitability by Market Segments 15.1.1.4. Sales Footprint 15.1.1.5. Strategy Overview 15.1.1.5.1. Marketing Strategy 15.1.2. Nauzene 15.1.2.1. Overview 15.1.2.2. Product Portfolio 15.1.2.3. Profitability by Market Segments 15.1.2.4. Sales Footprint 15.1.2.5. Strategy Overview 15.1.2.5.1. Marketing Strategy 15.1.3. Megafood 15.1.3.1. Overview 15.1.3.2. Product Portfolio 15.1.3.3. Profitability by Market Segments 15.1.3.4. Sales Footprint 15.1.3.5. Strategy Overview 15.1.3.5.1. Marketing Strategy 15.1.4. Webber Naturals 15.1.4.1. Overview 15.1.4.2. Product Portfolio 15.1.4.3. Profitability by Market Segments 15.1.4.4. Sales Footprint 15.1.4.5. Strategy Overview 15.1.4.5.1. Marketing Strategy 15.1.5. Pepto Bismol 15.1.5.1. Overview 15.1.5.2. Product Portfolio 15.1.5.3. Profitability by Market Segments 15.1.5.4. Sales Footprint 15.1.5.5. Strategy Overview 15.1.5.5.1. Marketing Strategy 15.1.6. Ginger People 15.1.6.1. Overview 15.1.6.2. Product Portfolio 15.1.6.3. Profitability by Market Segments 15.1.6.4. Sales Footprint 15.1.6.5. Strategy Overview 15.1.6.5.1. Marketing Strategy 15.1.7. Emetrol Chewables 15.1.7.1. Overview 15.1.7.2. Product Portfolio 15.1.7.3. Profitability by Market Segments 15.1.7.4. Sales Footprint 15.1.7.5. Strategy Overview 15.1.7.5.1. Marketing Strategy 15.1.8. Merck 15.1.8.1. Overview 15.1.8.2. Product Portfolio 15.1.8.3. Profitability by Market Segments 15.1.8.4. Sales Footprint 15.1.8.5. Strategy Overview 15.1.8.5.1. Marketing Strategy 15.1.9. Cipla 15.1.9.1. Overview 15.1.9.2. Product Portfolio 15.1.9.3. Profitability by Market Segments 15.1.9.4. Sales Footprint 15.1.9.5. Strategy Overview 15.1.9.5.1. Marketing Strategy 15.1.10. Sanofi 15.1.10.1. Overview 15.1.10.2. Product Portfolio 15.1.10.3. Profitability by Market Segments 15.1.10.4. Sales Footprint 15.1.10.5. Strategy Overview 15.1.10.5.1. Marketing Strategy 16. Assumptions & Acronyms Used 17. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Million) Forecast by Region, 2018-2033
Table 02: Global Market Value (US$ Million) Forecast by Indication, 2018-2033
Table 03: Global Market Value (US$ Million) Forecast by Distribution Channel, 2018-2033
Table 04: North America Market Value (US$ Million) Forecast by Country, 2018-2033
Table 05: North America Market Value (US$ Million) Forecast by Indication, 2018-2033
Table 06: North America Market Value (US$ Million) Forecast by Distribution Channel, 2018-2033
Table 07: Latin America Market Value (US$ Million) Forecast by Country, 2018-2033
Table 08: Latin America Market Value (US$ Million) Forecast by Indication, 2018-2033
Table 09: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2018-2033
Table 10: Europe Market Value (US$ Million) Forecast by Country, 2018-2033
Table 11: Europe Market Value (US$ Million) Forecast by Indication, 2018-2033
Table 12: Europe Market Value (US$ Million) Forecast by Distribution Channel, 2018-2033
Table 13: Asia Pacific Market Value (US$ Million) Forecast by Country, 2018-2033
Table 14: Asia Pacific Market Value (US$ Million) Forecast by Indication, 2018-2033
Table 15: Asia Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2018-2033
Table 16: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018-2033
Table 17: Middle East and Africa Market Value (US$ Million) Forecast by Indication, 2018-2033
Table 18: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2018-2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Million) by Indication, 2023-2033
Figure 02: Global Market Value (US$ Million) by Distribution Channel, 2023-2033
Figure 03: Global Market Value (US$ Million) by Region, 2023-2033
Figure 04: Global Market Value (US$ Million) Analysis by Region, 2018-2033
Figure 05: Global Market Value Share (%) and BPS Analysis by Region, 2023-2033
Figure 06: Global Market Y-o-Y Growth (%) Projections by Region, 2023-2033
Figure 07: Global Market Value (US$ Million) Analysis by Indication, 2018-2033
Figure 08: Global Market Value Share (%) and BPS Analysis by Indication, 2023-2033
Figure 09: Global Market Y-o-Y Growth (%) Projections by Indication, 2023-2033
Figure 10: Global Market Value (US$ Million) Analysis by Distribution Channel, 2018-2033
Figure 11: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033
Figure 12: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033
Figure 13: Global Market Attractiveness by Indication, 2023-2033
Figure 14: Global Market Attractiveness by Distribution Channel, 2023-2033
Figure 15: Global Market Attractiveness by Region, 2023-2033
Figure 16: North America Market Value (US$ Million) by Indication, 2023-2033
Figure 17: North America Market Value (US$ Million) by Distribution Channel, 2023-2033
Figure 18: North America Market Value (US$ Million) by Country, 2023-2033
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 22: North America Market Value (US$ Million) Analysis by Indication, 2018-2033
Figure 23: North America Market Value Share (%) and BPS Analysis by Indication, 2023-2033
Figure 24: North America Market Y-o-Y Growth (%) Projections by Indication, 2023-2033
Figure 25: North America Market Value (US$ Million) Analysis by Distribution Channel, 2018-2033
Figure 26: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033
Figure 28: North America Market Attractiveness by Indication, 2023-2033
Figure 29: North America Market Attractiveness by Distribution Channel, 2023-2033
Figure 30: North America Market Attractiveness by Country, 2023-2033
Figure 31: Latin America Market Value (US$ Million) by Indication, 2023-2033
Figure 32: Latin America Market Value (US$ Million) by Distribution Channel, 2023-2033
Figure 33: Latin America Market Value (US$ Million) by Country, 2023-2033
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 37: Latin America Market Value (US$ Million) Analysis by Indication, 2018-2033
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Indication, 2023-2033
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2023-2033
Figure 40: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2018-2033
Figure 41: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033
Figure 43: Latin America Market Attractiveness by Indication, 2023-2033
Figure 44: Latin America Market Attractiveness by Distribution Channel, 2023-2033
Figure 45: Latin America Market Attractiveness by Country, 2023-2033
Figure 46: Europe Market Value (US$ Million) by Indication, 2023-2033
Figure 47: Europe Market Value (US$ Million) by Distribution Channel, 2023-2033
Figure 48: Europe Market Value (US$ Million) by Country, 2023-2033
Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 52: Europe Market Value (US$ Million) Analysis by Indication, 2018-2033
Figure 53: Europe Market Value Share (%) and BPS Analysis by Indication, 2023-2033
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Indication, 2023-2033
Figure 55: Europe Market Value (US$ Million) Analysis by Distribution Channel, 2018-2033
Figure 56: Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033
Figure 57: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033
Figure 58: Europe Market Attractiveness by Indication, 2023-2033
Figure 59: Europe Market Attractiveness by Distribution Channel, 2023-2033
Figure 60: Europe Market Attractiveness by Country, 2023-2033
Figure 61: Asia Pacific Market Value (US$ Million) by Indication, 2023-2033
Figure 62: Asia Pacific Market Value (US$ Million) by Distribution Channel, 2023-2033
Figure 63: Asia Pacific Market Value (US$ Million) by Country, 2023-2033
Figure 64: Asia Pacific Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 67: Asia Pacific Market Value (US$ Million) Analysis by Indication, 2018-2033
Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Indication, 2023-2033
Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Indication, 2023-2033
Figure 70: Asia Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2018-2033
Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033
Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033
Figure 73: Asia Pacific Market Attractiveness by Indication, 2023-2033
Figure 74: Asia Pacific Market Attractiveness by Distribution Channel, 2023-2033
Figure 75: Asia Pacific Market Attractiveness by Country, 2023-2033
Figure 76: Middle East and Africa Market Value (US$ Million) by Indication, 2023-2033
Figure 77: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2023-2033
Figure 78: Middle East and Africa Market Value (US$ Million) by Country, 2023-2033
Figure 79: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018-2033
Figure 80: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 81: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 82: Middle East and Africa Market Value (US$ Million) Analysis by Indication, 2018-2033
Figure 83: Middle East and Africa Market Value Share (%) and BPS Analysis by Indication, 2023-2033
Figure 84: Middle East and Africa Market Y-o-Y Growth (%) Projections by Indication, 2023-2033
Figure 85: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2018-2033
Figure 86: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033
Figure 87: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033
Figure 88: Middle East and Africa Market Attractiveness by Indication, 2023-2033
Figure 89: Middle East and Africa Market Attractiveness by Distribution Channel, 2023-2033
Figure 90: Middle East and Africa Market Attractiveness by Country, 2023-2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What value is the market estimated to reach in 2023?
The global market size is estimated to be valued at US$ 356.8 million in 2023.
What was the global market size for 2022?
The market was reported at US$ 334 million in 2022.
What valuation is the market estimated to reach by 2033?
The market is expected to reach a valuation of US$ 712.9 million by 2033.
What value CAGR did the market exhibit over the last 4 years?
The market registered a CAGR of 5.6% over the last 4 years.
What is the projected CAGR for the market from 2023 to 2033?
The market is projected to witness a CAGR of 7.2% from 2023 to 2033.
Which indication of nausea relief chews leads to significant sales?
Gastroesophageal Reflux Disease is the top indication of nausea relief chews which is projected to witness significant demand with a projected CAGR of 7% from 2023 to 2033.
What is the expected market size in the United States by 2033?
The market in the United States is projected to witness a market size of US$ 172.1 million and is expected to grow at a 7% CAGR from 2023 to 2033.
Which are the key companies offering Nausea Relief Chews?
Key players in the market are Prestige Consumer Healthcare Inc., Megafood, Webber Naturals, Merck, Sanofi, Nauzene, Pepto Bismol, Ginger People, Emetrol Chewables and Cipla.
Nausea Relief Chews Market